Gastroparesis Outcome Longitudinal Database Enrolled Numerically

Status: Recruiting
Location: See location...
Intervention Type: Procedure, Device, Drug
Study Type: Observational
SUMMARY

GOLDEN is a longitudinal database of patients with the symptoms (Sx) of gastroparesis (Gp) who were seen and recorded at the University of Louisville from 2012 and is ongoing. Patients are enrolled and followed by sequential numbers and may include legacy patients seen at other centers by some of the same team and who are reported as part of the series. Outcome relate to patients Sx, survival, quality of life and other measures as detailed below, over time, regardless of whether any treatment was given or not. If treatments were administered GOLDEN allows for examination and stratification of outcome by groups both at baseline and at follow up.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Patients with the symptoms (Sx) of drug refractory gastroparesis

• Disordered nutrition by standardized assessment

• Ability to assess current symptom status

• Ability to measure other medical conditions

Locations
United States
Kentucky
University of Louisville
RECRUITING
Louisville
Contact Information
Primary
Thomas Abell, MD
thomas.abell@louisville.edu
(502)852-6991
Time Frame
Start Date: 2013-01-01
Estimated Completion Date: 2028-01-01
Participants
Target number of participants: 3000
Treatments
People presenting with the Sx of Gp
People presenting with the symptoms of gastroparesis. The three main interventions are GI neuromodulation, immunotherapy, and pyloric therapies.
Related Therapeutic Areas
Sponsors
Leads: University of Louisville

This content was sourced from clinicaltrials.gov